Extending the time frame for emergency intravenous thrombolytic therapy for treatment of acute ischemic stroke

Current Neurology and Neuroscience Reports

Volumn 9, Issue 1, 2009, Pages 299-309

  Adams Jr , Harold P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890735921     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-009-0001-1     Document Type: Article

References (5)

1. Hacke W, Albers G, Bogousslavsky J, et al.: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005, 36:66-73. (Pubitemid 40054177)
2. Furlan AJ, Eyding D, Albers GW, et al.: Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006, 37:1227-1231. (Pubitemid 43731867)
3. Kidwell CS, Alger JR, Saver JL: Evolving paradigms in neuroimaging of the ischemic penumbra. Stroke 2004, 35(Suppl 1):2662-2665. (Pubitemid 39461995)
4. Warach S: Measurement of the ischemic penumbra with MRI: it's about time. Stroke 2003, 34:2533-2534. (Pubitemid 37221977)
5. Albers GW, Thijs VN, Wechsler L, et al.: Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) Study. Ann Neurol 2006, 60:508-517. (Pubitemid 44871793)